PR Newswire Clinical TrialsOriginal article
Invenio Imaging Announces Completion of Enrollment in Landmark Study of AI-Based Image Analysis for Lung Cancer
Trial StartNIO Lung Cancer RevealPositive
AI Analysis
Summary
Invenio Imaging announced completion of patient enrollment in the ON-SITE pivotal study evaluating NIO Lung Cancer Reveal, an AI-based image analysis tool for lung cancer diagnosis.
Clinical Trial Data
Phase
pivotal
Outcome Details
Enrollment completion in ON-SITE pivotal study
Importance:5/10
Sentiment:
0.50
AIimage analysislung cancerenrollment completionpivotal study
Read the original article
Published by PR Newswire Clinical Trials on August 3, 2026 8:59 AM
